https://www.reuters.com/article/brief-shenzhen-hepalink-pharma-gets-regu/brief-shenzhen-hepalink-pharma-gets-regulatory-approval-for-hong-kong-ipo-idUSL4N2C82H5
April 20 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co Ltd:
* SAYS IT GETS CHINA SECURITIES REGULATOR'S APPROVAL FOR INITIAL H-SHARE OFFERING IN HONG KONG Source text in Chinese: bit.ly/2KjxFCl Further company coverage: (Reporting by Hong Kong newsroom)